Aspargo Labs appoints Sam Backenroth as chief financial officer to strengthen corporate and capital markets leadership
Aspargo Labs, Inc., a pharmaceutical company commercializing a highly absorbent oral suspension spray technology, has appointed Sam Back... See more
Patients with Crohn’s disease maintain steroid-free remission for three years with Lilly’s Omvoh (mirikizumab)
Long-term VIVID-2 data show more than 90% of patients with Crohn’s disease who achieved steroid-free remission at one year maintained control th... See more
International Brain Health Conference 2026 to focus on early intervention before dementia
The inaugural International Brain Health Conference 2026 in Edinburgh will unite global leaders to explore early detection, personalised interventions, and preventiv... See more
Hansa Biopharma’s BLA for imlifidase accepted by FDA
Hansa Biopharma’s Biologics License Application (BLA) for imlifidase has been accepted by the US Food and Drug Administration (FDA), marking a key milestone in the enzyme’s path toward enabling HLA-inco... See more
Lonza expands its Advanced Synthesis capabilities at Oss, integrating ADC and bioconjugate technologies to support discovery, development, and manufacturing from early-phase research through clinical supply.
Lonza has strengthened its Advanced Synthesis o... See more
